Improving HIV-1 Control in Africa with Long Acting Antiretrovirals

NCT05546242 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

540

Enrollment

OTHER

Sponsor class

Conditions

HIV-1-infection

Interventions

DRUG: Cabotegravir/Rilpivirine
DRUG: Antiretroviral

Sponsor

MRC/UVRI and LSHTM Uganda Research Unit

Collaborators

[object Object]